Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...

On Friday, LivePerson Inc (LPSN) stock saw a decline, ending the day at $1.33 which represents a decrease of $-0.05 or -3.62% from the prior close of $1.38. The stock opened at $1.37 and touched a low ...

Internet & Capital Markets Analyst Kulkarni, along with Udayan Bose, CEO of NetElixir, Alan Chapell, President of Chapell & Associates ...

Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...

In a report released today, Craig Irwin from Roth MKM maintained a Buy rating on Plug Power (PLUG – Research Report), with a price target of ...

Shares of Take-Two Interactive Software, Inc. (NASDAQ:TTWO – Get Free Report) have received an average rating of “Moderate ...

Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...

Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an early-stage biopharma that seeks to solve a key bottleneck, which is ...

Needham & Company LLC reiterated their buy rating on shares of Cryoport (NASDAQ:CYRX – Free Report) in a research report released on Friday,Benzinga reports. Needham & Company LLC currently has a $11.